Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
Blog Post
February 20, 2024
In a new note, I suggest there’s little evidence that aid (official development assistance, or ODA) spent on climate mitigation is actually reducing emissions. That’s not to say the finance is wasted: much will have been spent on projects with considerable development impact and some, surely, reduce...
CGD NOTES
February 20, 2024
An increasing proportion of official development assistance (ODA) is being dedicated to climate, and climate mitigation in particular. Even were that spending highly effective, and despite reaching about $30 billion in 2020, it is not large enough to finance investment that would significantly slow ...
Blog Post
February 09, 2024
Indonesia’s upcoming presidential election carries high stakes, demanding strong leadership to address long-standing challenges in child malnutrition and stunting at this pivotal moment. The issue of child stunting has become a flash point among the numerous campaign pledges for health and nutrition...
Blog Post
February 07, 2024
In global health, some from the northern hemisphere are lucky enough to escape the peak of winter by joining a special gathering in Bangkok. The Prince Mahidol Award Conference, affectionately called “PMAC”, is hosted annually at the end of January by the Royal Thai Government in Bangkok. It’s invit...
Blog Post
February 01, 2024
As the urgency and scale of development and climate challenges become more obvious and alarming, we have seen a surge in interest in how multilateral development banks (MDBs) can help low- and middle-income countries meet these challenges. Much of that focus has been on the volume of their finance, ...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
POLICY PAPERS
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...
WORKING PAPERS
January 29, 2024
A two-stage experiment disentangles the effect of various aspects of pay-for-performance contracts. The first is a lab-in-the-field experiment where 1,359 health workers are primed with a checklist of salient clinical tasks, then randomized within 690 clinics to receive no incentives, rewards, or pe...